Tubeless vs Tube PCNL in Pediatric Nephrolithiasis: A Randomized Controlled Trial.
NCT ID: NCT07183930
Last Updated: 2025-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
640 participants
INTERVENTIONAL
2024-10-01
2025-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the traditional method, a temporary tube (nephrostomy tube) is left in the kidney after surgery to drain urine. In the newer "tubeless" method, the tube is not used, and only a small internal stent may be placed. We want to find out if the tubeless method is as safe and effective as the traditional method, and whether it reduces pain, hospital stay, and the need for blood transfusions. The study involves 640 patients at Khyber Teaching Hospital in Peshawar, Pakistan. Each participant is randomly assigned to one of the two techniques.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The 18F Peel-way Sheath Versus the 18F Access Sheath With a Suction-evacuation Function MPCNL for the Management of 2-5cm Size Kidney Stones
NCT03206515
The Success of Pediatric Percutaneous Nephrolithotomy
NCT04299204
Clinical Efficacy of Mini-PCNLversus RIRS for the Management of Upper Urinary Tract Calculus (1-2.5 cm)
NCT06031103
Feasibility of Radiation-Free Percutaneus Nephrolithotomy for Kidney Stones
NCT06922006
Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary Drainage
NCT02055430
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recent advances in adult populations suggest that "tubeless" PCNL-where no external drainage tube is left-may reduce postoperative pain, decrease hospital stay, and improve recovery, without compromising safety. Evidence in children remains limited, mostly from small retrospective series.
This randomized controlled trial was conducted at Khyber Teaching Hospital, Peshawar, between October 2024 and March 2025. A total of 640 pediatric patients aged 6-18 years with renal stones \>10 mm were randomized into two groups: Group A (Tubeless PCNL, n=320) and Group B (Tube PCNL, n=320). All procedures were performed by a single experienced pediatric urologist using standardized mini-PCNL techniques.
The primary outcomes include operative time, hospital stay, blood transfusion requirement, and stone-free status on discharge. Secondary outcomes include postoperative pain scores, analgesic use, complications (graded by Clavien-Dindo classification), time to resumption of normal activities, and patient/family satisfaction.
By directly comparing the two approaches in a large pediatric cohort, this study provides high-quality evidence to determine whether tubeless PCNL should be considered the preferred technique in appropriately selected children.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tubeless PCNL
Percutaneous nephrolithotomy (PCNL) performed without nephrostomy tube placement. After complete stone clearance and confirmation of hemostasis, only a double-J stent is placed; the access tract is left to seal naturally.
Tubeless Percutaneous Nephrolithotomy (PCNL)
Mini-PCNL with tract dilation up to 18 Fr and stone fragmentation by pneumatic lithotripsy. Following clearance, a double-J stent is placed; no nephrostomy tube is inserted.
Tube PCNL
Standard PCNL performed with placement of a nephrostomy tube following stone clearance, along with a double-J stent.
Standard Tube Percutaneous Nephrolithotomy (PCNL)
Mini-PCNL with tract dilation up to 18 Fr and stone fragmentation by pneumatic lithotripsy. Following clearance, a 14 Fr nephrostomy tube and a double-J stent are placed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tubeless Percutaneous Nephrolithotomy (PCNL)
Mini-PCNL with tract dilation up to 18 Fr and stone fragmentation by pneumatic lithotripsy. Following clearance, a double-J stent is placed; no nephrostomy tube is inserted.
Standard Tube Percutaneous Nephrolithotomy (PCNL)
Mini-PCNL with tract dilation up to 18 Fr and stone fragmentation by pneumatic lithotripsy. Following clearance, a 14 Fr nephrostomy tube and a double-J stent are placed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Either gender
* Renal calculi larger than 10 mm on imaging
* Failed conservative management or extracorporeal shock wave lithotripsy (ESWL)
* Normal renal function
* Informed consent from parents/guardians
* Assent from children aged 12 years and above
Exclusion Criteria
* Congenital urological anomalies
* Active urinary tract infection at the time of surgery
* Known bleeding disorders or use of anticoagulant medication
* Significant comorbid medical conditions
* Pregnancy (in adolescent females)
6 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Khyber Teaching Hospital
OTHER
Lady Reading Hospital, Pakistan
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Waseem Ullah
Tariq
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tariq Ahmad, MBBS, FCPS
Role: PRINCIPAL_INVESTIGATOR
Khyber Teaching Hospital, Peshawar
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Khyber Teaching Hospital, Peshawar
Peshawar, Khyber Pakhtunkhwa, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KMC-IREB-533
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.